|
RSL3
- 英文名称:RSL3
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10932
- cas:1219810-16-8
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-11-14
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10932 |
| 用途 | 科研检测 |
| 英文名称 | RSL3 |
| 包装规格 | 1MG |
| CAS编号 | 1219810-16-8 |
| 别名 | RSL3 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by HPLC,;NMR (Conforms)
分子式:C23H21ClN2O5
分子量:440.88
溶剂:DMSO (45 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):GPX4 inhibitor / Ferroptosis inducer
Function / Pharmacology:RSL3 inhibits glutathione peroxidase (GPX4) inducing ferroptosis.1,2 Effectively induces ferroptosis in glioblastoma cells.3 Everolimus in combination with RSL3 synergistically inhibits the viability of renal cell carcinoma (RCC) cells suggesting a mechanism by which RCC drug resistance may be overcome.4
分子式:C23H21ClN2O5
分子量:440.88
溶剂:DMSO (45 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):GPX4 inhibitor / Ferroptosis inducer
Function / Pharmacology:RSL3 inhibits glutathione peroxidase (GPX4) inducing ferroptosis.1,2 Effectively induces ferroptosis in glioblastoma cells.3 Everolimus in combination with RSL3 synergistically inhibits the viability of renal cell carcinoma (RCC) cells suggesting a mechanism by which RCC drug resistance may be overcome.4



